Atlas Pipeline Partners was downgraded to hold at TheStreet Ratings.
Avon was initiated with a neutral rating at Credit Suisse. $19 price target. Consensus earnings expectations remain too high, Credit Suisse said.
Estee Lauder was initiated with an outperform rating at Credit Suisse. $82 price target. Company can deliver superior growth, Credit Suisse said.
Great Plains was upgraded at Bank of America/Merrill Lynch to buy from underperform. $27 price target. Regulatory outlook is improving, BofA/Merrill said.
Intel was initiated with a buy rating at Mizuho. $30 price target. 14 nm products could make a big splash in the market, Mizuho said.
Masco was upgraded to buy at TheStreet Ratings.
Mead Johnson was upgraded at Oppenheimer to outperform from perform. $100 price target. China child policy should be a tailwind for the infant formula business, Oppenheimer said.
Vail Resorts was upgraded at Credit Suisse to outperform from neutral. $81 price target. Estimates were also increased, as the company faces easy comps, Credit Suisse said.
Qualcomm was initiated with a buy rating at Mizuho. $88 price target. LTE-A chips should drive growth, Mizuho said.
Wellcare was initiated with a market perform rating at Leerink Swann. $72 price target. CEO suddenly left and the company may struggle to meet consensus earnings expectations, Leerink Swann said.
Stock Comments / EPS Changes
Altera price target was increased at Jefferies. Choice of Intel product is expected to provide competitive advantage, Jefferies said. $35 price target and hold rating.
Altera was cut from the Conviction Buy List at Goldman Sachs. Company lacks near-term catalysts, Goldman Sachs said. $39 price target.
Brocade estimates, price target were increased at BMO Capital. Estimates were increased through 2015. Company is realizing higher margins, BMO Capital said. Market perform rating and new $9.25 price target.
Chipotle price target was increased at Morgan Stanley. Shares are now seen reaching $594. Company deserves a premium multiple, Morgan Stanley said. Overweight rating.
Salesforce.com price target was increased at Canaccord Genuity. Company is positioned well for 2014, Canaccord Genuity said. Buy rating.
Salesforce.com price target was increased at UBS. Valuation call with raised revenue projections, UBS said. $66 price target and buy rating.
D.R. Horton numbers were lowered at UBS. The company lowered its own numbers across the board, UBS said. Estimates were adjusted to reflect moderate recovery, UBS said. $20 price target and neutral rating.
Envestnet EPS and price target were increased at UBS. The company increased its own numbers, UBS said. Driven by health conversion pipeline, strong advisor growth, market tailwinds and tuck-in acquisitions, UBS said. $38 price target and neutral rating.
Health Net numbers were reduced at Credit Suisse. Shares are now seen reaching $35. Estimates were also cut, given the company's new guidance, Credit Suisse said. Outperform rating.
Nortek price target was increased at Jefferies to $76. Reflects lower share count and interest, Jefferies said. Hold rating.
PNC Financial estimates were lowered through 2015 at J.P. Morgan. Slower-than-expected loan growth was partly offset by higher loan loss reserve releases, J.P. Morgan said. Overweight rating.
SunTrust Banks estimates were lowered at J.P. Morgan through 2015. Slower-than-expected loan growth was partly offset by higher loan loss reserve releases, J.P. Morgan said. Overweight rating.